Blueberries Medical Statistics
Blueberries Medical (1OA) Stock Statistics & Valuation Metrics
Total Valuation
Blueberries Medical has a market cap or net worth of EUR 3.12M. The enterprise value is EUR 4.94M.
- Market Cap
- EUR 3.12M
- Enterprise Value
- EUR 4.94M
Share Statistics
Blueberries Medical has 495,090,100 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 495,090,100
- Owned by Insiders
- 78.60%
- Owned by Institutions
- <0.01%
Financial Efficiency
Blueberries Medical’s return on equity (ROE) is -5.19 and return on invested capital (ROIC) is -300.40%.
- Return on Equity (ROE)
- -5.19
- Return on Assets (ROA)
- -2.45
- Return on Invested Capital (ROIC)
- -300.40%
- Return on Capital Employed (ROCE)
- -4.29
- Revenue Per Employee
- 6,123.235
- Profits Per Employee
- -32.66K
- Employee Count
- 51
- Asset Turnover
- 0.46
- Inventory Turnover
- 10.09
Valuation Ratios
The current PE Ratio of Blueberries Medical is -4.76. Blueberries Medical’s PEG ratio is -0.11.
- PE Ratio
- -4.76
- PS Ratio
- 17.80
- PB Ratio
- 172.76
- Price to FCF
- -8.15
- Price to Operating Cash Flow
- -8.15
- PEG Ratio
- -0.11
Income Statement
In the last 12 months, Blueberries Medical had revenue of 312.29K and earned -1.67M in profits. Earnings per share was -0.00.
- Revenue
- 312.29K
- Gross Profit
- 49.50K
- Operating Income
- -1.38M
- Pretax Income
- -1.67M
- Net Income
- -1.67M
- EBITDA
- -1.28M
- Earnings Per Share (EPS)
- -0.00
Cash Flow
In the last 12 months, operating cash flow was -607.78K and capital expenditures -4, giving a free cash flow of -607.78K billion.
- Operating Cash Flow
- -607.78K
- Free Cash Flow
- -607.78K
- Free Cash Flow per Share
- -0.00
Dividends & Yields
Blueberries Medical pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -12.28%
- Earnings Yield
- -21.59%
Stock Price Statistics
- Beta
- -2.34
- 52-Week Price Change
- 0.00%
- 50-Day Moving Average
- 0.01
- 200-Day Moving Average
- 0.01
- Relative Strength Index (RSI)
- ―
- Average Volume (3m)
- ―
Important Dates
Blueberries Medical upcoming earnings date is Nov 30, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 31, 2026
- Next Earnings Date
- Nov 30, 2026
- Ex-Dividend Date
- ―
Financial Position
Blueberries Medical as a current ratio of 0.95, with Debt / Equity ratio of 42.93%
- Current Ratio
- 0.95
- Quick Ratio
- 0.88
- Debt to Market Cap
- 0.03
- Net Debt to EBITDA
- -0.09
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Blueberries Medical has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Blueberries Medical EV to EBITDA ratio is -7.11, with an EV/FCF ratio of -8.14.
- EV to Sales
- 17.77
- EV to EBITDA
- -7.11
- EV to Free Cash Flow
- -8.14
- EV to Operating Cash Flow
- -8.14
Balance Sheet
Blueberries Medical has EUR 14.77K in cash and marketable securities with EUR 8,282.00 in debt, giving a net cash position of EUR 6,487.00 billion.
- Cash & Marketable Securities
- EUR 14.77K
- Total Debt
- EUR 8,282.00
- Net Cash
- EUR 6,487.00
- Net Cash Per Share
- EUR 0.00
- Tangible Book Value Per Share
- EUR 0.00
Margins
Gross margin is 36.89%, with operating margin of -272.03%, and net profit margin of -384.28%.
- Gross Margin
- 36.89%
- Operating Margin
- -272.03%
- Pretax Margin
- -384.28%
- Net Profit Margin
- -384.28%
- EBITDA Margin
- -249.98%
- EBIT Margin
- -268.26%
Analyst Forecast
The average price target for Blueberries Medical is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -41.06%
- EPS Growth Forecast
- 48.00%
